Microsoft Negotiates Partnership With Asus and 3 Dow Movers Demanding Attention
Microsoft Corporation (NASDAQ:MSFT): Current price $27.19
Microsoft is said to be in discussions with Asus regarding a potential licensing deal to offer Windows 8 mobile phones, according to The Wall Street Journal, which noted that Asus partnered with Google (NASDAQ:GOOG) on its Nexus 7 tablet but is still widely perceived as a PC maker.
Pfizer (NYSE:PFE): Current price $26.43
On Friday, Pfizer reported that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion concerning the conditional marketing authorization of bosutinib in the European Union for the treatment of adult patients suffering from chronic phase, accelerated phase, and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor, and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options. The CHMP’s positive opinion will be evaluated by the European Commission, which has the authority to approve medicines for the EU. Pfizer expects a decision from the Commission in the coming months.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.
United Technologies Corporation (NYSE:UTX): Current price $86.55
United Technologies’ Sikorsky Aircraft Corp. subsidiary, and The Boeing Company (NYSE:BA) reached a teaming accord on January 13th to submit a joint proposal in response to the United States Army Aviation Applied Technology Directorate solicitation for the Army’s Joint Multi-Role Technology Demonstrator Phase 1 program. The JMR TD supports the Defense Department ‘s Future Vertical Lift program to provide the next generation of vertical lift aircraft with greater performance, reliability and affordability. The Sikorsky and Boeing team will rival to build and fly one or more demonstrator aircraft in 2017 to be evaluated for next-generation vertical lift performance in a medium-lift-sized aircraft.
Johnson & Johnson (NYSE:JNJ): Current price $73.07
The company is scheduled to post its fourth quarter results before the open on Tuesday, with a conference call scheduled for 8:30 am ET. Analysts anticipate earnings of $1.17 on revenue of $17.67 billion, says First Call.
Don’t Miss: Are the Internet Power Players Changing?